HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fabien Calvo Selected Research

Protein Precursors

1/2011Identification of the myosin heavy polypeptide 9 as a downstream effector of the proprotein convertases in the human colon carcinoma HT-29 cells.
4/2010Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes.
9/2007Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fabien Calvo Research Topics

Disease

42Neoplasms (Cancer)
01/2022 - 11/2003
10Breast Neoplasms (Breast Cancer)
01/2017 - 07/2003
8Neoplasm Metastasis (Metastasis)
06/2014 - 07/2004
5Colonic Neoplasms (Colon Cancer)
09/2020 - 04/2006
4Carcinoma (Carcinomatosis)
04/2014 - 01/2008
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2013 - 11/2003
3Carcinogenesis
05/2012 - 07/2004
3Melanoma (Melanoma, Malignant)
08/2010 - 04/2010
3Renal Cell Carcinoma (Grawitz Tumor)
05/2010 - 01/2008
3Type 2 Diabetes Mellitus (MODY)
06/2008 - 05/2003
3Atherosclerosis
09/2007 - 10/2005
2Colorectal Neoplasms (Colorectal Cancer)
06/2014 - 01/2008
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2009 - 07/2002
2Ketosis
12/2008 - 06/2008
2Obesity
09/2007 - 10/2006
2Wounds and Injuries (Trauma)
02/2007 - 12/2003
2Glucose Intolerance
10/2006 - 05/2003
2Insulin Resistance
10/2006 - 05/2003
2Viremia
03/2006 - 07/2002
1Hepatocellular Carcinoma (Hepatoma)
04/2014
1Liver Cell Adenoma (Hepatocellular Adenoma)
04/2014
1Adenoma (Adenomas)
04/2014
1Squamous Cell Carcinoma of Head and Neck
03/2012
1Abdominal Pain (Pain, Abdominal)
10/2010
1Fever (Fevers)
10/2010
1Chills
10/2010
1Dermatofibrosarcoma
06/2010
1Brain Neoplasms (Brain Tumor)
06/2010
1Hypoxia (Hypoxemia)
12/2009
1Reticular dysgenesis
01/2009
1Deafness (Deaf Mutism)
01/2009
1Genomic Instability
11/2008

Drug/Important Bio-Agent (IBA)

11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015 - 12/2003
7Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
01/2015 - 11/2003
7Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
06/2014 - 09/2007
7Proteins (Proteins, Gene)FDA Link
03/2014 - 07/2004
7Matrix Metalloproteinases (MMPs)IBA
03/2012 - 11/2003
5Biomarkers (Surrogate Marker)IBA
09/2020 - 04/2010
5Peptide Hydrolases (Proteases)FDA Link
01/2015 - 07/2003
5Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2015 - 01/2008
5Imatinib Mesylate (Gleevec)FDA Link
10/2013 - 03/2003
5EnzymesIBA
04/2010 - 12/2003
4Protein Isoforms (Isoforms)IBA
05/2010 - 04/2008
4Insulin (Novolin)FDA Link
12/2008 - 05/2003
3Biological ProductsIBA
01/2022 - 12/2003
3FurinIBA
03/2014 - 10/2007
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
03/2012 - 01/2007
3Peptides (Polypeptides)IBA
01/2011 - 07/2003
3Protein PrecursorsIBA
01/2011 - 09/2007
2ErbB Receptors (EGF Receptor)IBA
01/2017 - 03/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2015 - 01/2008
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2015 - 08/2006
2Pharmaceutical PreparationsIBA
01/2015 - 06/2009
2CateninsIBA
04/2014 - 05/2012
2IGF Type 1 Receptor (IGF 1 Receptor)IBA
03/2014 - 01/2008
2Mitogen-Activated Protein KinasesIBA
05/2012 - 04/2008
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2011 - 09/2005
2Metalloproteases (Metalloproteinases)IBA
01/2011 - 01/2007
2Growth Factor ReceptorsIBA
01/2011 - 09/2007
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
05/2010 - 07/2002
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
04/2010 - 01/2008
2Messenger RNA (mRNA)IBA
02/2010 - 09/2008
2DNA (Deoxyribonucleic Acid)IBA
06/2008 - 07/2002
2ImmunosorbentsIBA
01/2008 - 12/2003
2Tyrosine Kinase InhibitorsIBA
10/2007 - 11/2003
2Tissue Inhibitor of Metalloproteinase-1IBA
10/2007 - 12/2003
2Glucose (Dextrose)FDA LinkGeneric
10/2006 - 05/2003
2AmphiregulinIBA
09/2005 - 11/2003
2Complementary DNA (cDNA)IBA
09/2005 - 07/2004
2Epidermal Growth Factor (EGF)IBA
11/2003 - 07/2003
1human ERBB2 proteinIBA
01/2017
1Phenobarbital (Luminal)FDA Link
01/2016
1Cyclin A2IBA
10/2015
1Telomerase (Telomerase Reverse Transcriptase)IBA
10/2015
1CyclinsIBA
10/2015
1Lysine (L-Lysine)FDA Link
10/2015
1MethyltransferasesIBA
10/2015
1Aflatoxin B1 (Aflatoxin B)IBA
05/2015
1LigandsIBA
01/2015
1IntegrinsIBA
10/2014
1SerpinsIBA
06/2014
1Oral ContraceptivesIBA
04/2014
1platelet-derived growth factor AIBA
03/2014
1Platelet-Derived Growth FactorIBA
03/2014
1SubtilisinIBA
03/2014
1ChromatinIBA
05/2012
1Myosins (Myosin)IBA
01/2011
1Interleukin-2 (IL2)IBA
10/2010
1bromohydrin pyrophosphateIBA
10/2010
1IpilimumabIBA
06/2010
1Sunitinib (Sutent)FDA Link
05/2010
1adenylate kinase 2IBA
01/2009
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
11/2008
1AntibodiesIBA
06/2008

Therapy/Procedure

17Therapeutics
05/2020 - 12/2003
2Immunotherapy
01/2019 - 11/2018
1Precision Medicine
01/2020
1Lasers (Laser)
01/2011
1Radiotherapy
04/2010
1Drug Therapy (Chemotherapy)
04/2010